Clinical Trial Results:
A double blind, randomized, placebo controlled cross-over study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female subjects with Female Sexual Dysfunction in combination with SSRI use.
Summary
|
|
EudraCT number |
2008-002735-32 |
Trial protocol |
NL |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Oct 2022
|
First version publication date |
28 Oct 2022
|
Other versions |
|
Summary report(s) |
Efficacy of Testosterone combined with a PDE5 inhibitor and testosterone combined with serotonin 1A receptor agonist in women with SSRI-induced sexual dysfunction. |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.